Stryker misses quarterly profit and revenue estimates
The medical device maker reported adjusted earnings of $2.60 per share on revenue of $6.02 billion. Results were impacted by soft demand and a cyberattack.
Xurve View
Insights:
Xurve View
STRYKER CORP missed first-quarter profit and revenue estimates as demand for complex surgical implants softened in the United States. Adjusted EPS reached $2.60, trailing LSEG estimates of $2.98, while total revenue of $6.02B fell short of the $6.35B target. The miss reflects operational friction following a March cyberattack and shifting demand in the competitive orthopedics market.
